UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 315

Sortiert nach

Nonimmune-acquired factor XIII deficiency: a cause of high volume and delayed postoperative hemorrhage

Blood coagulation & fibrinolysis, 2020-12, Vol.31 (8), p.511

2020

Volltextzugriff (PDF)

Acquired FXI deficiency in a systemic lupus erythematosus patient: Evolution and coagulation phenotypic changed to lupus anticoagulant during immunosuppressive therapy

International journal of laboratory hematology, 2022-12, Vol.44 (6), p.e269-e274

2022

Volltextzugriff (PDF)

Ubiquitin binds the amyloid β peptide and interferes with its clearance pathways

Chemical science (Cambridge), 2019-03, Vol.1 (9), p.2732-2742

2019

Volltextzugriff (PDF)

Climate Policy after the 2015 Paris Climate Conference

1, 2022

Volltextzugriff (PDF)

92 Autoimmune manifestations in chronic myelomonocytic leukemia

Leukemia research, 2011, Vol.35, p.S35-S35

2011

Volltextzugriff (PDF)

Ubiquitin binds the amyloid β peptide and interferes with its clearance pathways† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c8sc03394c

Chemical science (Cambridge), 2019-01, Vol.10 (9), p.2732-2742

2019

Volltextzugriff (PDF)

Renal function and plasma dabigatran level measured at trough by diluted thrombin time assay

Medicina (Buenos Aires), 2017, Vol.77 (1), p.31-36

2017

Volltextzugriff (PDF)

Alternative consent methods used in the multinational, pragmatic, randomised clinical trial SafeBoosC-III

Trials, 2024-04, Vol.25 (1), p.236-236, Article 236

2024

Volltextzugriff (PDF)

Face à l’irresponsabilité: la dynamique de la solidarité

Alain Supiot

2018

Volltextzugriff (PDF)

Evolution over a 15-year period of clinical characteristics and outcomes of critically ill patients with community-acquired bacteremia

Critical care medicine, 2013-01, Vol.41 (1), p.76-83

2013

Volltextzugriff (PDF)

Clinical and molecular epidemiology of community‐acquired, healthcare‐associated and nosocomial methicillin‐resistant Staphylococus aureus in Spain

Clinical microbiology and infection, 2009-12, Vol.15 (12), p.1111-1118

2009

Volltextzugriff (PDF)

Introduction: international climate policy after Paris – an update on a changing world

Climate Policy after the 2015 Paris Climate Conference, 2022, Vol.1, p.1-14

1, 2022

Volltextzugriff (PDF)

Climate change after Paris: from turning point to transformation

Climate Policy after the 2015 Paris Climate Conference, 2022, Vol.1, p.23-29

1, 2022

Volltextzugriff (PDF)

Small group, big impact: how AILAC helped shape the Paris Agreement

Climate Policy after the 2015 Paris Climate Conference, 2022, Vol.1, p.85-99

1, 2022

Volltextzugriff (PDF)

Global trade and promotion of cleantech industry: a post-Paris agenda

Climate Policy after the 2015 Paris Climate Conference, 2022, Vol.1, p.116-124

1, 2022

Volltextzugriff (PDF)

The Paris Agreement: resolving the inconsistency between global goals and national contributions

Climate Policy after the 2015 Paris Climate Conference, 2022, Vol.1, p.30-46

1, 2022

Volltextzugriff (PDF)

Precaution and post-caution in the Paris Agreement: adaptation, loss and damage and finance

Climate Policy after the 2015 Paris Climate Conference, 2022, Vol.1, p.47-61

1, 2022

Volltextzugriff (PDF)

US-proofing the Paris Climate Agreement

Climate Policy after the 2015 Paris Climate Conference, 2022, Vol.1, p.100-115

1, 2022

Volltextzugriff (PDF)

The Paris Agreement: China's ‘New Normal’ role in international climate negotiations

Climate Policy after the 2015 Paris Climate Conference, 2022, Vol.1, p.62-72

1, 2022

Volltextzugriff (PDF)

Responsibility and liability for climate loss and damage after Paris

Climate Policy after the 2015 Paris Climate Conference, 2022, Vol.1, p.73-84

1, 2022

Volltextzugriff (PDF)

Climate policy after the Paris 2015 climate conference

Climate Policy after the 2015 Paris Climate Conference, 2022, Vol.1, p.15-22

1, 2022

Volltextzugriff (PDF)

Detailed statistical analysis plan for a secondary Bayesian analysis of the SafeBoosC-III trial: a multinational, randomised clinical trial assessing treatment guided by cerebral oximetry monitoring versus usual care in extremely preterm infants

Trials, 2023-11, Vol.24 (1), p.737-737, Article 737

2023

Volltextzugriff (PDF)

Prognostic value of the expression of MDR-1 in acute myeloid leukemia

Medicina (Buenos Aires), 2003, Vol.63 (4), p.277-282

2003

Volltextzugriff (PDF)

Visceral and cutaneous leishmaniasis in Huesca. Epidemiologic aspects

Anales españoles de pediatría, 1985-12, Vol.23 (8), p.551

1985

Volltextzugriff (PDF)

Función renal y nivel plasmático de dabigatrán en el valle, medido por un ensayo de trombina diluida

Medicina (Buenos Aires), 2017-02, Vol.77 (1), p.31-36

2017

Volltextzugriff (PDF)

1 – 25 von 315

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(216)
Mit Volltextzugriff
(283)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(121)
Life Sciences & Biomedicine
(72)
Physical Sciences
(49)
Humans
(42)
Technology
(28)
Social Sciences
(25)
Law
(23)
Male
(23)
Materials Science
(20)
Female
(19)
Materials Science, Multidisciplinary
(18)
Chemistry
(17)
Physics
(17)
Government & Law
(15)
International Law
(15)
Biochemistry & Molecular Biology
(14)
Environmental Sciences & Ecology
(13)
Environmental Studies
(13)
Climate Change
(12)
Electrochromism
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Nonimmune-acquired factor XIII deficiency: a cause of high volume and delayed postoperative hemorrhage

Acquired FXI deficiency in a systemic lupus erythematosus patient: Evolution and coagulation phenotypic changed to lupus anticoagulant during immunosuppressive therapy

Ubiquitin binds the amyloid β peptide and interferes with its clearance pathways

Climate Policy after the 2015 Paris Climate Conference

92 Autoimmune manifestations in chronic myelomonocytic leukemia

Ubiquitin binds the amyloid β peptide and interferes with its clearance pathways† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c8sc03394c

Renal function and plasma dabigatran level measured at trough by diluted thrombin time assay

Alternative consent methods used in the multinational, pragmatic, randomised clinical trial SafeBoosC-III

Face à l’irresponsabilité: la dynamique de la solidarité

Evolution over a 15-year period of clinical characteristics and outcomes of critically ill patients with community-acquired bacteremia

Clinical and molecular epidemiology of community‐acquired, healthcare‐associated and nosocomial methicillin‐resistant Staphylococus aureus in Spain

Introduction: international climate policy after Paris – an update on a changing world

Climate change after Paris: from turning point to transformation

Small group, big impact: how AILAC helped shape the Paris Agreement

Global trade and promotion of cleantech industry: a post-Paris agenda

The Paris Agreement: resolving the inconsistency between global goals and national contributions

Precaution and post-caution in the Paris Agreement: adaptation, loss and damage and finance

US-proofing the Paris Climate Agreement

The Paris Agreement: China's ‘New Normal’ role in international climate negotiations

Responsibility and liability for climate loss and damage after Paris

Climate policy after the Paris 2015 climate conference

Detailed statistical analysis plan for a secondary Bayesian analysis of the SafeBoosC-III trial: a multinational, randomised clinical trial assessing treatment guided by cerebral oximetry monitoring versus usual care in extremely preterm infants

Prognostic value of the expression of MDR-1 in acute myeloid leukemia

Visceral and cutaneous leishmaniasis in Huesca. Epidemiologic aspects

Función renal y nivel plasmático de dabigatrán en el valle, medido por un ensayo de trombina diluida

Suchergebnisse filtern